HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Isao Matsui-Yuasa Selected Research

Ehrlich Tumor Carcinoma

5/2010Comparison of glutathione reductase activity and the intracellular glutathione reducing effects of 13 derivatives of 1'-acetoxychavicol acetate in Ehrlich ascites tumor cells.
1/20091'-Acetoxychavicol acetate-induced cytotoxicity is accompanied by a rapid and drastic modulation of glutathione metabolism.
4/2008(1'S)-Acetoxychavicol acetate and its enantiomer inhibit tumor cells proliferation via different mechanisms.
12/2007Mechanism of growth inhibitory effect of cape aloe extract in ehrlich ascites tumor cells.
4/2004Reactive oxygen species-independent G1 arrest induced by evening primrose extract in Ehrlich ascites tumor cells.
6/2003Role of intracellular reactive oxygen species and mitochondrial dysfunction in evening primrose extract-induced apoptosis in Ehrlich ascites tumor cells.
2/2002Involvement of protein tyrosine phosphorylation and reduction of cellular sulfhydryl groups in cell death induced by 1' -acetoxychavicol acetate in Ehrlich ascites tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Isao Matsui-Yuasa Research Topics

Disease

7Ehrlich Tumor Carcinoma
05/2010 - 02/2002
6Neoplasms (Cancer)
04/2014 - 02/2002
2Retinoblastoma (Glioblastoma, Retinal)
01/2008 - 05/2002
1Hepatocellular Carcinoma (Hepatoma)
04/2014
1Body Weight (Weight, Body)
07/2012
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2012
1Fibrosis (Cirrhosis)
12/2011
1Necrosis
04/2011
1Liver Neoplasms (Liver Cancer)
01/2009
1Autoimmune Diseases (Autoimmune Disease)
01/2008
1Leukemia
03/2006
1Neoplasm Metastasis (Metastasis)
07/2003

Drug/Important Bio-Agent (IBA)

51'-acetoxychavicol acetateIBA
04/2014 - 02/2002
3TeaIBA
01/2009 - 05/2002
3Retinoblastoma ProteinIBA
04/2008 - 05/2002
2Glutathione (Reduced Glutathione)IBA
05/2010 - 01/2009
2Lipase (Acid Lipase)FDA Link
04/2008 - 03/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2004 - 06/2003
1SodiumIBA
04/2014
1Butyrates (Butyrate)IBA
04/2014
1AMP-Activated Protein KinasesIBA
04/2014
1Carbon Tetrachloride (Tetrachloromethane)IBA
07/2012
1Ethanol (Ethyl Alcohol)IBA
07/2012
1Glucose (Dextrose)FDA LinkGeneric
12/2011
1CollagenIBA
04/2011
1Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
05/2010
1EnzymesIBA
01/2009
1Cyclin EIBA
01/2008
1Tacrolimus (Prograf)FDA LinkGeneric
01/2008
1Methylene Chloride (Dichloromethane)IBA
12/2007
1Acetates (Acetic Acid Esters)IBA
03/2006
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2003
1polyphenolsIBA
05/2002
1gallocatechol (epigallocatechin)IBA
05/2002
1Tyrosine (L-Tyrosine)FDA Link
02/2002

Therapy/Procedure

1Organ Transplantation
01/2008